Phoenix Nest is a collaborative company focused on treating Sanfilippo Syndrome (Mucopolysaccharidosis (MPS) IIIB, IIIC, and IIID).  Their goal is to bring these treatments to market as quickly as possible.  They are working with leading academics and have engaged in a  strategy of licensing key technologies to facilitate this goal.

Biotechnology

Phoenix Nest

Jill Wood

Srikanth Singamsetty

The Scientific Team at Phoenix Nest is dedicated to researching and developing treatments for Sanfilippo Syndrome (MPS IIIB, IIIC, and IIID). Comprising a Scientific Director and multiple Scientific Advisors, the team collaborates with leading academics and leverages licensed key technologies to expedite the process of bringing effective treatments to market.

Scientific Team

About

Team members